6: Episode 6: Approval of Oral Semaglutide and PIONEER Trials with Dr. Aroda

from HCPLive Podcasts · host HCPLive.com

The approval of oral semaglutide, an oral GLP-1 receptor agonist, could mark the beginning of a new era in the treatment of diabetes. We sat down with PIONEER investigator Vanita Aroda, MD, of Brigham and Women's, to learn more about the impact of this approval.

Episode metadata supplied by the publisher feed · Published Sep 23, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

6: Episode 6: Approval of Oral Semaglutide and PIONEER Trials with Dr. Aroda

0:00 9:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of HCPLive Podcasts?

This episode is 9 minutes long.

When was this HCPLive Podcasts episode published?

This episode was published on September 23, 2019.

Can I download this HCPLive Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!